Growing adoption rates towards automated hematology Instruments coupled with increasing preferences towards high sensitivity point-of-care (POC) hematology testing is expected to drive the hematology analyzers and reagents market during the forecast period. Furthermore, rapid technological advancement such as the introduction of basic flow cytometry techniques and the development of high throughput hematology analyzers are expected to be high impact rendering drivers of this market.
Hematology analyzers and reagents market is segmented into products and services. On the basis of the product, the market is classified into instruments and consumables. Hematology instruments are further bifurcated into slide strainers/makers and analyzers. Analyzers are highly specialized computers, which help in determining the count, presence, and different types of cellular elements in the blood sample. All these processes help in screening and analyzing the disease hence are extensively used by doctors and physicians globally. On the other hand, the hematology consumables market is divided into controls & calibrators, stains, and regents. Among these stains is more popular as compared to others, owing to their extensive use by the doctors or lab technicians to separate the white blood cells (WCB) from the blood.
On the basis of end-use the hematology analyzers & reagents market is segmented into, stand-alone hospitals, commercial organizations, clinical testing labs, and research institutes. Among these clinical testing, labs held the largest market share in 2013. Factors attributing to the dominance of this segment is due to the increasing prevalence of blood-related disorders such as hereditary spherocytosis, chronic granulomatous disease, chronic lead poisoning, and sickle cell disease, identification of abnormal hemoglobin’s, and cytochemistries on blood and bone marrow. North America dominated the market in terms of revenue share in2013. The Asia Pacific region is expected to witness lucrative growth in the coming six years owing to the presence of untapped opportunity especially in the developing economies of India and China.
The major players of hematology analyzers and reagents market are Beckman Coulter, Sysmex Corporation, HORIBA Ltd, Abbott Laboratories, Bio-Rad Laboratories, Siemens AG, Mindray Medical International Limited, Boule Diagnostics AB, Roche Diagnostics, and Nihon Kohden Corporation. The market players are involved in developing novel technologies to meet the requirements of the users. These companies are also involved in various mergers & acquisitions to maintain substantial market share.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.